Insmed Inc
(STU:IM8N)
€
67
0.5 (0.75%)
Market Cap: 11.95 Bil
Enterprise Value: 11.50 Bil
PE Ratio: 0
PB Ratio: 25.75
GF Score: 63/100 Insmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020 / 06:10PM GMT
Release Date Price:
€23.2
(-4.13%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Great. Well, good afternoon, everyone. Welcome to the 2:10 session here at the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I am the firm's European Biopharma Analyst, and I cover U.S. Biopharma as well.
I've got the great pleasure of hosting today, Insmed for a fireside chat. It will be about 40 minutes or so. With me joining from the company is Will Lewis, Chairman and CEO of the company; as well as Sara Bonstein, who's Chief Financial Officer.
So Will, great to see you again. I wish we were doing this out in Southern California as we did last year, but hopefully, we'll be able to get to do this back out there this time next year.
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
I know we're all missing that experience.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot